Catch-up vaccination protocols US Medical PG Practice Questions and MCQs
Practice US Medical PG questions for Catch-up vaccination protocols. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Catch-up vaccination protocols US Medical PG Question 1: An 11-year-old boy is brought to his pediatrician by his parents for the routine Tdap immunization booster dose that is given during adolescence. Upon reviewing the patient’s medical records, the pediatrician notes that he was immunized according to CDC recommendations, with the exception that he received a catch-up Tdap immunization at the age of 8 years. When the pediatrician asks the boy’s parents about this delay, they inform the doctor that they immigrated to this country 3 years ago from Southeast Asia, where the child had not been immunized against diphtheria, tetanus, and pertussis. Therefore, he received a catch-up series at 8 years of age, which included the first dose of the Tdap vaccine. Which of the following options should the pediatrician choose to continue the boy’s immunization schedule?
- A. A single dose of Td vaccine at 18 years of age
- B. A single dose of Td vaccine now
- C. No further vaccination needed
- D. A single dose of Tdap vaccine now
- E. A single dose of Tdap vaccine at 13 years of age (Correct Answer)
Catch-up vaccination protocols Explanation: ***A single dose of Tdap vaccine at 13 years of age***
- The CDC recommends a **minimum interval of 5 years** between Tdap doses when Tdap is given as part of a catch-up series.
- Since this patient received his first Tdap at age 8, the earliest he should receive the adolescent booster is at **age 13** (5 years later).
- This timing ensures adequate spacing while still providing the recommended adolescent booster for **pertussis, tetanus, and diphtheria** protection.
- The 5-year interval prevents excessive antigen exposure and optimizes immune response.
*A single dose of Tdap vaccine now*
- Giving Tdap now would result in only a **3-year interval** from the previous Tdap dose at age 8.
- This violates the CDC recommendation of a **minimum 5-year interval** between Tdap doses.
- Shorter intervals may increase local reactogenicity without improving protection.
*A single dose of Td vaccine now*
- While this would provide tetanus and diphtheria protection, it would **not protect against pertussis**, which is a critical component of adolescent vaccination.
- The Tdap vaccine is specifically recommended for adolescents to boost waning pertussis immunity.
- Additionally, giving it now would still be earlier than the recommended 5-year interval from the previous pertussis-containing vaccine.
*A single dose of Td vaccine at 18 years of age*
- This option would result in a **10-year gap** from the last pertussis-containing vaccine, leaving the adolescent vulnerable during high-risk years.
- The adolescent Tdap booster is specifically timed for ages 11-13 to protect during peak transmission periods in middle and high school.
- Waiting until 18 would miss the critical window for pertussis protection.
*No further vaccination needed*
- While the patient completed a catch-up series, the CDC still recommends an **adolescent Tdap booster** even for those who received Tdap in a catch-up series.
- The adolescent booster is important to maintain immunity against pertussis, which wanes significantly over time.
- The booster should be given at age 13 to maintain the 5-year minimum interval.
Catch-up vaccination protocols US Medical PG Question 2: A 12-month-old girl is brought to her pediatrician for a checkup and vaccines. The patient’s mother wants to send her to daycare but is worried about exposure to unvaccinated children and other potential sources of infection. The toddler was born at 39 weeks gestation via spontaneous vaginal delivery. She is up to date on all vaccines. She does not walk yet but stands in place and can say a few words. The toddler drinks formula and eats a mixture of soft vegetables and pureed meals. She has no current medications. On physical exam, the vital signs include: temperature 37.0°C (98.6°F), blood pressure 95/50 mm Hg, pulse 130/min, and respiratory rate 28/min. The patient is alert and responsive. The remainder of the exam is unremarkable. Which of the following is most appropriate for this patient at this visit?
- A. Meningococcal vaccine
- B. Gross motor workup and evaluation
- C. Rotavirus vaccine
- D. Referral for speech pathology
- E. MMR vaccine (Correct Answer)
Catch-up vaccination protocols Explanation: ***MMR vaccine***
- The **measles, mumps, and rubella (MMR) vaccine** is recommended for administration at **12-15 months of age**.
- This timing offers protection against these common childhood diseases, which is especially important for children attending **daycare**.
*Meningococcal vaccine*
- The routine **meningococcal vaccine (MenACWY)** is typically recommended for adolescents at **11-12 years of age**, with a booster at 16 years.
- While there are specific circumstances for earlier vaccination (e.g., high-risk conditions), it is **not routine** for a 12-month-old.
*Gross motor workup and evaluation*
- The patient's motor development, standing in place but not yet walking, is **within the normal range** for a 12-month-old.
- A definitive **gross motor workup** would generally be considered if there were more significant delays or regressions.
*Rotavirus vaccine*
- The **rotavirus vaccine** series is typically given at **2, 4, and 6 months of age**, with the final dose administered no later than **8 months of age**.
- A 12-month-old is **outside the recommended age range** for initiating or completing this vaccine series.
*Referral for speech pathology*
- Saying "a few words" at 12 months is **within the normal developmental milestone** for expressive language at this age.
- A referral for **speech pathology** would generally be indicated for more significant language delays.
Catch-up vaccination protocols US Medical PG Question 3: A 3-month-old African American boy presents to his pediatrician’s office for his routine well visit. He was born full-term from an uncomplicated vaginal delivery. He is exclusively breastfeeding and not receiving any medications or supplements. Today, his parents report no issues or concerns with their child. He is lifting his head for brief periods and smiling. He has received only 2 hepatitis B vaccines. Which of the following is the correct advice for this patient’s parents?
- A. He should be sleeping more.
- B. He should have his serum lead level checked to screen for lead intoxication.
- C. He should start vitamin D supplementation. (Correct Answer)
- D. He should start rice cereal.
- E. He needs a 3rd hepatitis B vaccine.
Catch-up vaccination protocols Explanation: ***He should start vitamin D supplementation.***
- **Exclusively breastfed** infants, regardless of maternal vitamin D intake, require **vitamin D supplementation** due to insufficient amounts in breast milk.
- The recommended daily dose is **400 IU** starting from the first few days of life, to prevent **rickets** and promote bone health.
- **African American infants** have an additional risk factor due to increased skin melanin content, which reduces cutaneous vitamin D synthesis from sunlight exposure.
*He should be sleeping more.*
- A 3-month-old infant typically sleeps between **14-17 hours per day**, with **waking periods to feed** and interact.
- The case description does not indicate any concerns with the child's sleep patterns, and **developmental milestones** like lifting his head and smiling are being met.
*He should have his serum lead level checked to screen for lead intoxication.*
- **Lead screening** is not routinely recommended for all infants unless specific **risk factors** are present, such as living in an older home with lead paint, or having siblings with elevated lead levels.
- There are no reported risk factors for lead exposure in this patient's history.
*He should start rice cereal.*
- Introduction of solid foods, such as rice cereal, is typically recommended around **6 months of age**, when the infant shows signs of **developmental readiness**.
- These signs include **head control**, sitting with support, and showing interest in food.
*He needs a 3rd hepatitis B vaccine.*
- The **third dose of the hepatitis B vaccine** is typically administered between **6 and 18 months of age**.
- At 3 months old, the infant is not yet due for his third dose.
Catch-up vaccination protocols US Medical PG Question 4: A 9-month-old boy is brought to a pediatrician by his parents for routine immunization. The parents say they have recently immigrated to the United States from a developing country, where the infant was receiving immunizations as per the national immunization schedule for that country. The pediatrician prepares a plan for the infant’s immunizations as per standard US guidelines. Looking at the plan, the parents ask why the infant needs to be vaccinated with injectable polio vaccine, as he had already received an oral polio vaccine back in their home country. The pediatrician explains to them that, as per the recommended immunization schedule for children and adolescents in the United States, it is important to complete the schedule of immunizations using the injectable polio vaccine (IPV). He also mentions that IPV is considered safer than OPV, and IPV has some distinct advantages over OPV. Which of the following statements best explains the advantage of IPV over OPV to which the pediatrician is referring?
- A. IPV is known to produce higher titers of mucosal IgG antibodies than OPV
- B. IPV is known to produce virus-specific CD4+ T cells that produce interleukins and interferons to control polio viruses
- C. IPV is known to produce higher titers of mucosal IgA antibodies than OPV
- D. IPV is known to produce higher titers of serum IgG antibodies than OPV (Correct Answer)
- E. IPV is known to produce virus-specific CD8+ T cells that directly kill polio-infected cells
Catch-up vaccination protocols Explanation: ***IPV is known to produce higher titers of serum IgG antibodies than OPV***
- The **injectable polio vaccine (IPV)** is an **inactivated vaccine** that primarily induces a systemic immune response, leading to high levels of **serum IgG antibodies**. These antibodies are crucial for preventing **viremia** and subsequently protecting against paralytic poliomyelitis.
- While OPV (oral polio vaccine) induces both mucosal and humoral immunity, IPV's strength lies in its ability to generate robust systemic immunity without the risk of vaccine-associated paralytic polio (VAPP), a rare but serious complication of OPV.
*IPV is known to produce higher titers of mucosal IgG antibodies than OPV*
- IPV primarily stimulates **systemic immunity** rather than strong mucosal immunity, meaning it does not typically produce higher titers of mucosal IgG antibodies than OPV.
- Mucosal immunity, especially IgA, is better stimulated by vaccines administered orally, like **OPV**, as it directly interacts with the gut-associated lymphoid tissue.
*IPV is known to produce virus-specific CD4+ T cells that produce interleukins and interferons to control polio viruses*
- Both IPV and OPV can induce **CD4+ T cell responses**, but this statement does not highlight a distinct advantage of IPV over OPV.
- While CD4+ T cells are important for immune coordination and antibody production, the primary advantage of IPV is its **safety profile** and systemic antibody levels, not necessarily a superior CD4+ T cell response.
*IPV is known to produce higher titers of mucosal IgA antibodies than OPV*
- **OPV**, being an oral vaccine, is highly effective at inducing a strong **mucosal IgA response** in the gut, which is important for preventing viral shedding and transmission.
- **IPV**, administered parenterally, produces minimal to no mucosal IgA response, making this statement incorrect.
*IPV is known to produce virus-specific CD8+ T cells that directly kill polio-infected cells*
- **Cytotoxic CD8+ T cells** are primarily involved in clearing cells infected with intracellular pathogens.
- While both vaccines may induce some cellular immunity, their primary mechanism for protecting against polio is through **neutralizing antibodies**, and the induction of CD8+ T cells is not the principal advantage of IPV over OPV.
Catch-up vaccination protocols US Medical PG Question 5: A 1-year-old girl is brought to the physician for a well-child examination. She has no history of serious illness. She receives a vaccine in which a polysaccharide is conjugated to a carrier protein. Which of the following pathogens is the most likely target of this vaccine?
- A. Hepatitis A virus
- B. Varicella zoster virus
- C. Streptococcus pneumoniae (Correct Answer)
- D. Bordetella pertussis
- E. Clostridium tetani
Catch-up vaccination protocols Explanation: ***Streptococcus pneumoniae***
- This pathogen is a common cause of **pneumonia**, **otitis media**, and **meningitis** in young children. The **pneumococcal conjugate vaccine (PCV)** targets *Streptococcus pneumoniae*'s polysaccharide capsule by conjugating it to a carrier protein.
- Conjugating the polysaccharide to a protein carrier allows for a **T-cell-dependent immune response**, which is crucial for eliciting a robust and long-lasting antibody response in infants and young children, whose immune systems are not yet mature enough to respond effectively to unconjugated polysaccharide antigens.
*Hepatitis A virus*
- The vaccine for **Hepatitis A virus** is an **inactivated vaccine** containing whole killed virus particles, not a polysaccharide conjugated to a carrier protein.
- It is typically given to children to prevent **Hepatitis A infection**, which causes liver inflammation.
*Varicella zoster virus*
- The **varicella vaccine** for **Varicella zoster virus** is a **live, attenuated vaccine**, meaning it contains a weakened form of the live virus.
- This vaccine aims to prevent **chickenpox** and is not a polysaccharide-protein conjugate vaccine.
*Bordetella pertussis*
- The vaccine for **Bordetella pertussis** (whooping cough) is part of the **DTaP vaccine** and is an **acellular vaccine**, containing purified components of the bacterium.
- These components are primarily **toxoids** (inactivated toxins) or other bacterial proteins, not polysaccharides.
*Clostridium tetani*
- The vaccine for **Clostridium tetani** is a **toxoid vaccine**, meaning it contains an inactivated form of the **tetanus toxin**.
- This is part of the **DTaP vaccine** and works by stimulating an immune response against the toxin, not bacterial polysaccharides.
Catch-up vaccination protocols US Medical PG Question 6: A parent presents to her pediatrician requesting information about immunizations for her newborn. The pediatrician explains about basic principles of immunization, types of vaccines, possible adverse effects, and the immunization schedule. Regarding how immunizations work, the pediatrician explains that there are mainly 2 types of vaccines. The first type of vaccine provides stronger and more lasting immunity as it induces both cellular and humoral immune responses. The second type of vaccine produces mainly a humoral response only, and its overall efficacy is less as compared to the first type. Which of the following vaccines belongs to the first type of vaccine that the pediatrician is talking about?
- A. Hepatitis A vaccine
- B. Polio vaccine (Salk)
- C. Yellow fever vaccine (Correct Answer)
- D. Rabies vaccine
- E. Hepatitis B vaccine
Catch-up vaccination protocols Explanation: ***Yellow fever vaccine***
- The Yellow fever vaccine is a **live-attenuated vaccine**, which mimics natural infection and effectively stimulates both **cellular and humoral immune responses**, leading to strong and long-lasting immunity.
- Live-attenuated vaccines contain a weakened form of the pathogen, allowing for replication within the host and robust immune system activation.
*Hepatitis A vaccine*
- The Hepatitis A vaccine is an **inactivated vaccine**, which primarily induces a **humoral (antibody-mediated) immune response**.
- Inactivated vaccines generally do not stimulate a strong cellular immune response and often require booster doses to maintain protective immunity.
*Polio vaccine (Salk)*
- The Salk polio vaccine is an **inactivated polio vaccine (IPV)**, meaning it contains killed viral particles.
- As an inactivated vaccine, it mainly elicits a **humoral immune response** producing circulating antibodies but less mucosal or cellular immunity.
*Rabies vaccine*
- The Rabies vaccine is an **inactivated vaccine** given after exposure or for pre-exposure prophylaxis.
- It primarily induces a **humoral antibody response** rather than a strong cellular immune response.
*Hepatitis B vaccine*
- The Hepatitis B vaccine is a **recombinant vaccine**, containing only a portion of the viral antigen (HBsAg).
- This type of vaccine primarily stimulates a **humoral immune response** leading to antibody production, which is effective but does not typically induce a strong cellular response like live vaccines.
Catch-up vaccination protocols US Medical PG Question 7: A 4-month-old boy is brought to the physician by his parents for a well-child examination. He has cystic fibrosis diagnosed by newborn screening. His parents report frequent feedings and large-volume and greasy stools. His 4-year-old brother has autism. Current medications include bronchodilators, pancreatic enzyme supplements, and fat-soluble vitamins. He is at the 18th percentile for height and 15th percentile for weight. Scattered wheezes are heard throughout both lung fields. Examination shows a distended and tympanic abdomen with no tenderness or guarding. Which of the following is a contraindication for administering one or more routine vaccinations?
- A. Allergy to egg protein
- B. History of cystic fibrosis
- C. History of febrile seizures
- D. Fever of 38.2°C (100.7°F) following previous vaccinations
- E. History of intussusception (Correct Answer)
Catch-up vaccination protocols Explanation: ***History of intussusception***
- A history of **intussusception** is a **contraindication for rotavirus vaccine** administration, as the vaccine itself has a small risk of intussusception, particularly with the first dose.
- The rotavirus vaccine is part of routine childhood immunizations, so this would be a contraindication for one of the routine vaccines.
*Allergy to egg protein*
- Egg allergy is a contraindication primarily for yellow fever vaccine and some influenza vaccines, which are typically not routine vaccinations for a 4-month-old. Many flu vaccines are egg-free or can be safely administered to those with egg allergy under supervision.
- The MMR vaccine is generally safe for those with egg allergy since the amount of egg protein is negligible.
*History of cystic fibrosis*
- **Cystic fibrosis** itself is **not a contraindication** to routine vaccinations; in fact, patients with chronic conditions like CF are often *more* encouraged to receive vaccinations to prevent severe infections.
- The patient's symptoms (poor growth, greasy stools, wheezing) are manifestations of CF, not reasons to defer vaccination.
*History of febrile seizures*
- A history of **febrile seizures** is generally **not a contraindication** to routine vaccinations.
- Parents should be counseled on fever management after vaccination, but the risk of recurrent febrile seizures is not increased by vaccination to a level that warrants deferral.
*Fever of 38.2°C (100.7°F) following previous vaccinations*
- A **low-grade fever** after vaccination is a common and **expected immune response**, not a contraindication for future doses.
- Only a **severe allergic reaction** (e.g., anaphylaxis) to a previous dose of a vaccine or one of its components is a contraindication to subsequent doses of that specific vaccine.
Catch-up vaccination protocols US Medical PG Question 8: A 4-year-old boy is brought to the emergency department with difficulty breathing. His mother reports that he developed a fever last night and began to have trouble breathing this morning. The boy was born at 39 weeks gestation via spontaneous vaginal delivery. He is unvaccinated (conscientious objection by the family) and is meeting all developmental milestones. At the hospital, his vitals are temperature 39.8°C (103.6°F), pulse 122/min, respiration rate 33/min, blood pressure 110/66 mm Hg, and SpO2 93% on room air. On physical examination, he appears ill with his neck hyperextended and chin protruding. His voice is muffled and is drooling. The pediatrician explains that there is one particular bacteria that commonly causes these symptoms. At what age should the patient have first received vaccination to prevent this condition from this particular bacteria?
- A. At birth
- B. At 2-months-old (Correct Answer)
- C. Between 9- and 12-months-old
- D. At 6-months-old
- E. Between 12- and 15-months-old
Catch-up vaccination protocols Explanation: ***At 2-months-old***
- The clinical presentation with **high fever**, **difficulty breathing**, **neck hyperextension**, **muffled voice**, and **drooling** in an unvaccinated child strongly suggests **epiglottitis**, likely caused by *Haemophilus influenzae type b* (Hib).
- The **Hib vaccine** is routinely given starting at **2 months of age** as part of the multi-dose primary series to protect against this life-threatening condition.
*At birth*
- While some vaccines like **Hepatitis B** are given at birth, the Hib vaccine is not typically administered at this age.
- Vaccinating at birth would not align with the standard immunization schedule for *Haemophilus influenzae type b*.
*Between 9- and 12-months-old*
- This age range typically corresponds to the **measles, mumps, and rubella (MMR)** and **varicella** vaccines, or a booster dose of other vaccines, not the initial primary series for Hib.
- Delaying the first Hib vaccination until this age would leave infants vulnerable during a critical period.
*At 6-months-old*
- By 6 months, a child should have already received at least **two doses** of the Hib vaccine if following the recommended schedule.
- Administering the first dose at 6 months would significantly delay protection against invasive Hib disease.
*Between 12- and 15-months-old*
- This age range is typically when the **final booster dose** of the Hib vaccine is given, not the initial vaccination.
- The primary series for Hib should have been completed much earlier to provide timely protection.
Catch-up vaccination protocols US Medical PG Question 9: An 8-year-old boy is brought to the physician because of a 7-day history of a progressively worsening cough. The cough occurs in spells and consists of around 5–10 coughs in succession. After each spell he takes a deep, noisy breath. He has vomited occasionally following a bout of coughing. He had a runny nose for a week before the cough started. His immunization records are unavailable. He lives in an apartment with his father, mother, and his 2-week-old sister. The mother was given a Tdap vaccination 11 years ago. The father's vaccination records are unavailable. His temperature is 37.8°C (100.0°F). Examination shows no abnormalities. His leukocyte count is 42,000/mm3. Throat swab culture and PCR results are pending. Which of the following are the most appropriate recommendations for this family?
- A. Administer oral azithromycin to the baby and father and Tdap vaccination to the father
- B. Administer oral azithromycin to all family members and Tdap vaccination to the father and mother (Correct Answer)
- C. Administer oral azithromycin to all family members and Tdap vaccination to the father
- D. Administer oral erythromycin to all family members and Tdap vaccination to the father
- E. Administer oral trimethoprim-sulfamethoxazole to the father and baby and Tdap vaccination to the father
Catch-up vaccination protocols Explanation: ***Administer oral azithromycin to all family members and Tdap vaccination to the father and mother***
- The 8-year-old boy presents with classic symptoms of **pertussis** (whooping cough), including **paroxysmal cough**, post-tussive emesis, and a preceding catarrhal phase (runny nose). The high **leukocyte count** further supports this diagnosis. Given his exposure, the 2-week-old sister is at high risk of severe sequelae.
- **Prophylactic antibiotics** (e.g., azithromycin) are indicated for all close contacts, especially infants and pregnant women, to prevent the spread of *Bordetella pertussis*. Tdap vaccination is recommended for the father (whose vaccination status is unknown) and the mother, as her last Tdap was 11 years ago, and there is a high-risk infant in the household.
*Administer oral azithromycin to the baby and father and Tdap vaccination to the father*
- This option misses administering **prophylactic antibiotics** to the mother and **Tdap vaccination** to the mother, both of whom are close contacts and have a high-risk infant in the household.
- The mother's Tdap vaccination from 11 years ago may no longer provide sufficient protection, especially with a neonate in the home.
*Administer oral azithromycin to all family members and Tdap vaccination to the father*
- While this option correctly suggests prophylactic antibiotics for all family members, it incorrectly omits **Tdap vaccination for the mother**, whose last vaccination was 11 years ago.
- Updating the mother's Tdap vaccination status is crucial, especially in a household with a 2-week-old infant.
*Administer oral erythromycin to all family members and Tdap vaccination to the father*
- **Erythromycin** is an alternative macrolide for pertussis treatment/prophylaxis, but **azithromycin** is preferred due to a shorter course and better tolerability, especially in infants.
- This option also incorrectly omits **Tdap vaccination for the mother**.
*Administer oral trimethoprim-sulfamethoxazole to the father and baby and Tdap vaccination to the father*
- **Trimethoprim-sulfamethoxazole** is a less preferred antibiotic for pertussis prophylaxis/treatment and is generally reserved for patients who cannot tolerate macrolides.
- This option incorrectly limits antibiotic prophylaxis to only the father and baby, excluding the mother and the 8-year-old boy, and also omits **Tdap vaccination for the mother**.
Catch-up vaccination protocols US Medical PG Question 10: A 6-year-old male who recently immigrated to the United States from Asia is admitted to the hospital with dyspnea. Physical exam reveals a gray pseudomembrane in the patient's oropharynx along with lymphadenopathy. The patient develops myocarditis and expires on hospital day 5. Which of the following would have prevented this patient's presentation and decline?
- A. Increased CD4+ T cell count
- B. Circulating IgG against AB exotoxin (Correct Answer)
- C. Increased IgM preventing bacterial invasion
- D. Improved IgE release from mast cells
- E. Secretory IgA against viral proteins
Catch-up vaccination protocols Explanation: ***Circulating IgG against AB exotoxin***
- This clinical presentation (gray pseudomembrane, dyspnea, lymphadenopathy, and myocarditis) is classic for **diphtheria**, caused by **Corynebacterium diphtheriae**.
- The severe manifestations, including myocarditis, are due to the **diphtheria exotoxin**, an AB toxin. **Circulating IgG antibodies** against this toxin would neutralize it, preventing its toxic effects and the ensuing severe disease.
*Increased CD4+ T cell count*
- While T cells are crucial for overall immune function, diphtheria's pathogenicity is primarily mediated by its **exotoxin**, not directly by bacterial invasion or intracellular survival requiring a strong cellular immune response.
- An increased CD4+ T cell count alone would not directly neutralize the circulating diphtheria toxin, which is the key to preventing the severe systemic complications like myocarditis.
*Increased IgM preventing bacterial invasion*
- IgM antibodies are important in the **primary immune response** and can agglutinate bacteria, but they are generally less effective at neutralizing toxins compared to IgG.
- The critical determinant of severe diphtheria is the **systemic spread of the exotoxin**, not simply bacterial invasion, and IgM would be less effective in preventing toxin-mediated damage.
*Improved IgE release from mast cells*
- IgE antibodies are primarily involved in **allergic reactions** and defense against parasites.
- They play no significant role in immunity against bacterial infections like diphtheria or in neutralizing bacterial exotoxins.
*Secretory IgA against viral proteins*
- Secretory IgA primarily functions in **mucosal immunity** to prevent the adherence and invasion of pathogens at mucosal surfaces.
- It is effective against **viral and bacterial pathogens** at mucosal sites but would not prevent the systemic effects of a bacterial exotoxin that has already been absorbed, nor would it specifically target viral proteins in a bacterial infection.
More Catch-up vaccination protocols US Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
